Cms Antipsychotic Guidelines 2025
Cms Antipsychotic Guidelines 2025. The centers for medicare and medicaid services’ (cms’) recently released final rule finalizes changes to the medicare advantage (ma) prescription drug program. In this rule, cms proposes to begin validating this data in a pilot program beginning with data submitted in cy 2024, affecting the fy 2025 payment.
The centers for medicare and medicaid services’ (cms’) recently released final rule finalizes changes to the medicare advantage (ma) prescription drug program. Cms issued its final 2025 medicare advantage and part d rule april 4, setting new standards around marketing, broker payments, and prior authorization.